These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12806570)

  • 1. Omeprazole reduces clozapine plasma concentrations. A case report.
    Frick A; Kopitz J; Bergemann N
    Pharmacopsychiatry; 2003 May; 36(3):121-3. PubMed ID: 12806570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?
    Wagner S; Varet-Legros MG; Fabre C; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2011 May; 67(5):533-4. PubMed ID: 21057941
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
    Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
    Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma clozapine levels in tardive dyskinesia.
    Pollack S; Lieberman J; Kleiner D; Szymanski S; Kane J; Borenstein M; Cooper T
    Psychopharmacol Bull; 1993; 29(2):257-62. PubMed ID: 8290674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenytoin on plasma clozapine concentrations in two patients.
    Miller DD
    J Clin Psychiatry; 1991 Jan; 52(1):23-5. PubMed ID: 1988414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature.
    de Leon J
    J Clin Psychiatry; 2004 Aug; 65(8):1144-5. PubMed ID: 15323602
    [No Abstract]   [Full Text] [Related]  

  • 8. Coadministration of clozapine and fluvoxamine in psychotic patients--clinical experience.
    Lammers CH; Deuschle M; Weigmann H; Härtter S; Hiemke C; Heese C; Heuser I
    Pharmacopsychiatry; 1999 Mar; 32(2):76-7. PubMed ID: 10333167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Switching to e-cigarettes affects drug concentration].
    Berm EJ; Ruijsbroek R; Loonen AJ; Goethals KR; Wilffert B; van Hasselt F
    Ned Tijdschr Geneeskd; 2015; 159():A9090. PubMed ID: 26200424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nefazodone on clozapine plasma concentrations.
    Taylor D; Bodani M; Hubbeling A; Murray R
    Int Clin Psychopharmacol; 1999 May; 14(3):185-7. PubMed ID: 10435773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
    Eap CB; Bender S; Jaquenoud Sirot E; Cucchia G; Jonzier-Perey M; Baumann P; Allorge D; Broly F
    J Clin Psychopharmacol; 2004 Apr; 24(2):214-9. PubMed ID: 15206669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report.
    de Leon J; Diaz FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1059-63. PubMed ID: 14499324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy, psychosis and clozapine.
    Langosch JM; Trimble MR
    Hum Psychopharmacol; 2002 Mar; 17(2):115-9. PubMed ID: 12404701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible levomepromazine-clozapine interaction: two case reports.
    Bugamelli F; Mandrioli R; Kenndler E; Bartoletti C; Boncompagni G; Raggi MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):567-70. PubMed ID: 17174461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational antipsychotic polypharmacy.
    Kennedy NB; Procyshyn RM
    Can J Clin Pharmacol; 2000; 7(3):155-9. PubMed ID: 11044761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.
    Lesche D; Mostafa S; Everall I; Pantelis C; Bousman CA
    Pharmacogenomics J; 2020 Apr; 20(2):192-201. PubMed ID: 31616047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High clozapine concentrations in leukocytes in a patient who developed leukocytopenia.
    Bergemann N; Abu-Tair F; Aderjan R; Kopitz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1068-71. PubMed ID: 17467133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of the effect of omeprazole on clozapine metabolism.
    Mookhoek EJ; Loonen AJ
    Pharm World Sci; 2004 Jun; 26(3):180-2. PubMed ID: 15230368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.
    Gee S; Dixon T; Docherty M; Shergill SS
    BMC Psychiatry; 2015 Aug; 15():195. PubMed ID: 26265348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
    Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
    J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.